Corient Private Wealth
TNGX icon

Corient Private Wealth’s Tango Therapeutics TNGX Stock Holding History

Corient Private Wealth’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
+38,971
New +$963K ﹤0.01% 1693
2026
Q1 		– Sell
-10,529
Closed -$93.3K – 2986
2025
Q4 		$93.3K Sell
10,529
-971
-8% -$8.37K ﹤0.01% 2558
2025
Q3 		$96.6K Buy
+11,500
New +$77.8K ﹤0.01% 2455

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Corient Private Wealth's TNGX Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 38,971 shares worth $1.22M. The stake represents ﹤0.01% of the portfolio and ranks #1693 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in TNGX as recently as Q4 2025.

Corient Private Wealth first reported a position in TNGX in Q3 2025 and has held it in 3 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Corient Private Wealth held 38,971 shares of Tango Therapeutics worth $1.22M as of Q2 2026.
  • Tango Therapeutics was a new Corient Private Wealth position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1693 holding.
  • Corient Private Wealth first reported a position in Tango Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.